Cas no 1188153-49-2 (Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate)

Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate is a brominated thiazole derivative featuring a trifluoromethylphenyl substituent, making it a valuable intermediate in organic synthesis and medicinal chemistry. The presence of the bromo and ester functional groups enhances its reactivity, enabling further functionalization via cross-coupling or nucleophilic substitution reactions. The electron-withdrawing trifluoromethyl group contributes to its stability and potential bioactivity, particularly in the development of pharmaceuticals and agrochemicals. This compound is particularly useful in constructing heterocyclic frameworks and as a precursor for more complex molecules. Its well-defined structure and synthetic versatility make it a preferred choice for researchers in drug discovery and material science applications.
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate structure
1188153-49-2 structure
Product Name:Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
CAS No:1188153-49-2
MF:C13H9BrF3NO2S
MW:380.180271863937
MDL:MFCD11220991
CID:1040164
PubChem ID:53399673
Update Time:2025-06-07

Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate Chemical and Physical Properties

Names and Identifiers

    • Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
    • Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
    • 2-Bromo-4-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid ethyl ester
    • AG-A-38000
    • AK-88237
    • ANW-67431
    • CTK6F8013
    • KB-252583
    • 5-Thiazolecarboxylic acid, 2-broMo-4-[4-(trifluoroMethyl)phenyl]-, ethyl ester
    • Ethyl2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
    • ethyl 2-bromo-4-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate
    • CS-0061559
    • 1188153-49-2
    • MFCD11220991
    • AKOS016006775
    • DTXSID50694655
    • W16944
    • DB-061415
    • AS-73558
    • MDL: MFCD11220991
    • Inchi: 1S/C13H9BrF3NO2S/c1-2-20-11(19)10-9(18-12(14)21-10)7-3-5-8(6-4-7)13(15,16)17/h3-6H,2H2,1H3
    • InChI Key: GJROTGCXQSNRKG-UHFFFAOYSA-N
    • SMILES: BrC1=NC(=C(C(=O)OCC)S1)C1C=CC(C(F)(F)F)=CC=1

Computed Properties

  • Exact Mass: 378.94895g/mol
  • Monoisotopic Mass: 378.94895g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 21
  • Rotatable Bond Count: 5
  • Complexity: 375
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 5.1
  • Topological Polar Surface Area: 67.4?2

Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A059003220-1g
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
1188153-49-2 95%
1g
$530.00 2023-09-04
TRC
E075530-50mg
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
1188153-49-2
50mg
$ 410.00 2022-06-05
TRC
E075530-100mg
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
1188153-49-2
100mg
$ 680.00 2022-06-05
Chemenu
CM189262-1g
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
1188153-49-2 95%
1g
$580 2021-08-05
Chemenu
CM189262-1g
Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate
1188153-49-2 95%+
1g
$615 2023-02-18
eNovation Chemicals LLC
D761987-100mg
5-Thiazolecarboxylic acid, 2-broMo-4-[4-(trifluoroMethyl)phenyl]-, ethyl ester
1188153-49-2 95%
100mg
$335 2024-06-07
eNovation Chemicals LLC
D761987-250mg
5-Thiazolecarboxylic acid, 2-broMo-4-[4-(trifluoroMethyl)phenyl]-, ethyl ester
1188153-49-2 95%
250mg
$540 2024-06-07
Ambeed
A656236-1g
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
1188153-49-2 95+%
1g
$564.0 2024-04-25
A2B Chem LLC
AE28068-100mg
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
1188153-49-2 95%
100mg
$310.00 2024-04-20
A2B Chem LLC
AE28068-250mg
Ethyl 2-bromo-4-(4-(trifluoromethyl)phenyl)thiazole-5-carboxylate
1188153-49-2 95%
250mg
$510.00 2024-04-20

Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate Related Literature

Additional information on Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate

Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate (CAS No. 1188153-49-2): A Comprehensive Overview

Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate (CAS No. 1188153-49-2) is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its intricate molecular structure, presents a unique combination of functional groups that make it a promising candidate for various applications. The presence of a bromine atom, a trifluoromethyl group, and a thiazole core provides a rich scaffold for further chemical modifications and biological evaluations.

The thiazole moiety is particularly noteworthy due to its prevalence in biologically active molecules. Thiazole derivatives have been extensively studied for their antimicrobial, anti-inflammatory, and anticancer properties. In particular, the substitution pattern of the thiazole ring, as seen in this compound, can significantly influence its pharmacological activity. The 2-bromo substituent enhances the electrophilicity of the molecule, making it more reactive in cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures, which is often required in drug discovery.

The 4-(4-(trifluoromethyl)-phenyl) group adds another layer of functionality to the molecule. The trifluoromethyl group is known for its ability to modulate lipophilicity and metabolic stability, which are critical factors in drug design. Additionally, the phenyl ring provides a hydrophobic pocket that can interact with biological targets. This combination of features makes Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate an attractive intermediate for synthesizing novel compounds with enhanced biological activity.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific enzymes and receptors involved in disease pathways. Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate has been explored as a precursor in the synthesis of inhibitors for enzymes such as kinases and proteases. For instance, thiazole derivatives have shown promise in inhibiting Janus kinases (JAKs), which are implicated in various inflammatory diseases. The bromine substituent on the thiazole ring allows for easy modification through transition-metal-catalyzed reactions, enabling the construction of diverse libraries of compounds for high-throughput screening.

The pharmaceutical industry has also been interested in this compound for its potential applications in oncology. Preclinical studies have indicated that certain thiazole derivatives exhibit inhibitory effects on tumor growth by interfering with key signaling pathways. The structural features of Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate make it a valuable building block for designing molecules that can selectively target cancer cells while minimizing side effects on healthy tissues.

Beyond pharmaceuticals, this compound has found utility in agrochemical research. The combination of a bromine atom and a trifluoromethyl group enhances the bioactivity of thiazole derivatives against various pests and pathogens. Researchers have been exploring its potential as a precursor for developing new-generation pesticides with improved efficacy and environmental safety.

The synthesis of Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate involves multi-step organic transformations that highlight the versatility of modern synthetic chemistry techniques. The process typically begins with the functionalization of readily available starting materials such as bromothiophenes and aromatic aldehydes. Palladium-catalyzed cross-coupling reactions play a crucial role in assembling the complex core structure of the molecule. These reactions not only provide efficient routes to the desired product but also allow for precise control over regioselectivity and stereochemistry.

The role of computational chemistry in optimizing synthetic routes cannot be overstated. Molecular modeling studies have been instrumental in predicting reaction outcomes and identifying optimal reaction conditions. By leveraging computational tools, chemists can accelerate the discovery process and minimize experimental trials.

In conclusion, Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate represents a fascinating example of how structural complexity can be harnessed to develop molecules with significant biological activity. Its unique combination of functional groups makes it a versatile intermediate for pharmaceutical and agrochemical applications. As research continues to uncover new therapeutic targets and synthetic methodologies, compounds like Ethyl 2-bromo-4-(4-(trifluoromethyl)-phenyl)thiazole-5-carboxylate will undoubtedly play a crucial role in shaping the future of drug discovery.

Recommended suppliers
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
SunaTech Inc.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
SunaTech Inc.
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent